Holdings of Select Pharmaceuticals Portfolio
Fidelity Select Portfolios · 46 declared positions · as of Feb 28, 2026
Original filing · Net assets 1.5B $ · Ten largest lines: 75.3 % of the equity sleeve
Sector breakdown
- Health care 62.5 %
- Unattributed 37.5 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 87.2 %
- EUR 7.6 %
- CHF 5.2 %
The quoted currency of each line, as declared.
Country breakdown
- US 62.5 %
- GB 15.1 %
- BE 6.7 %
- CH 5.2 %
- KY 3.3 %
- IE 2.9 %
- DE 1.9 %
- CA 1.0 %
- NL 0.7 %
- DK 0.4 %
- SG 0.3 %
Shares computed on the equity sleeve.
| Country | Lines | Value | Share |
|---|---|---|---|
| US | 30 | 938.3M $ | 62.49 % |
| GB | 2 | 227.3M $ | 15.14 % |
| BE | 3 | 100.5M $ | 6.70 % |
| CH | 2 | 78M $ | 5.20 % |
| KY | 1 | 49.4M $ | 3.29 % |
| IE | 1 | 43.3M $ | 2.88 % |
| DE | 2 | 29M $ | 1.93 % |
| CA | 2 | 14.9M $ | 0.99 % |
| NL | 1 | 11M $ | 0.73 % |
| DK | 1 | 5.7M $ | 0.38 % |
| SG | 1 | 4.1M $ | 0.28 % |
Positions
| Company | Shares | Value | Weight |
|---|---|---|---|
| Eli Lilly & Co | 362,801 | 381.7M $ | 25.18 % |
| GSK PLC | 2,581,360 | 152.6M $ | 10.07 % |
| Johnson & Johnson | 459,700 | 114.2M $ | 7.53 % |
| UCB SA | 254,500 | 75.9M $ | 5.01 % |
| Roche Holding AG | 157,090 | 74.8M $ | 4.93 % |
| AstraZeneca PLC | 358,250 | 74.7M $ | 4.93 % |
| Gilead Sciences Inc | 472,500 | 70.4M $ | 4.64 % |
| Merck & Co Inc | 561,536 | 69.5M $ | 4.59 % |
| Elanco Animal Health Inc | 2,536,200 | 67M $ | 4.42 % |
| LEGEND BIOTECH CORP | 2,598,400 | 49.4M $ | 3.26 % |
| Jazz Pharmaceuticals PLC | 227,700 | 43.3M $ | 2.85 % |
| Moderna Inc | 688,800 | 36.9M $ | 2.43 % |
| Royalty Pharma PLC | 750,500 | 34.7M $ | 2.29 % |
| Viatris Inc | 1,729,600 | 25.8M $ | 1.70 % |
| Financiere de Tubize SA | 91,587 | 24.5M $ | 1.62 % |
| BioNTech SE | 132,653 | 14.6M $ | 0.96 % |
| Merck KGaA | 94,700 | 14.3M $ | 0.95 % |
| Biogen Inc | 73,000 | 14M $ | 0.92 % |
| Ocular Therapeutix Inc | 1,331,717 | 11.9M $ | 0.79 % |
| Beam Therapeutics Inc | 415,400 | 11.8M $ | 0.78 % |
| Xenon Pharmaceuticals Inc | 268,600 | 11.6M $ | 0.77 % |
| uniQure NV | 705,578 | 11M $ | 0.73 % |
| Capricor Therapeutics Inc | 389,900 | 10.9M $ | 0.72 % |
| PTC Therapeutics Inc | 155,600 | 10.6M $ | 0.70 % |
| Kymera Therapeutics Inc | 102,000 | 9.3M $ | 0.61 % |
| Phibro Animal Health Corp | 150,755 | 8.2M $ | 0.54 % |
| Axsome Therapeutics Inc | 48,900 | 8M $ | 0.53 % |
| Annexon Inc | 1,264,100 | 7.1M $ | 0.47 % |
| Ascendis Pharma A/S | 24,400 | 5.7M $ | 0.38 % |
| Corcept Therapeutics Inc | 158,100 | 5.6M $ | 0.37 % |
| Intellia Therapeutics Inc | 384,500 | 5.3M $ | 0.35 % |
| Crinetics Pharmaceuticals Inc | 122,800 | 5M $ | 0.33 % |
| Harmony Biosciences Holdings Inc | 158,577 | 4.5M $ | 0.30 % |
| Arrowhead Pharmaceuticals Inc | 65,400 | 4.1M $ | 0.27 % |
| WaVe Life Sciences Ltd | 296,800 | 4.1M $ | 0.27 % |
| Vera Therapeutics Inc | 100,700 | 4.1M $ | 0.27 % |
| Amylyx Pharmaceuticals Inc | 257,800 | 3.9M $ | 0.26 % |
| Disc Medicine Inc | 53,800 | 3.6M $ | 0.24 % |
| Definium Therapeutics Inc | 188,000 | 3.3M $ | 0.22 % |
| Idorsia Ltd | 639,660 | 3.3M $ | 0.21 % |
| Summit Therapeutics Inc | 169,304 | 2.8M $ | 0.19 % |
| Edgewise Therapeutics Inc | 83,600 | 2.5M $ | 0.17 % |
| ArriVent Biopharma Inc | 107,000 | 2.5M $ | 0.16 % |
| Viking Therapeutics Inc | 64,300 | 2.2M $ | 0.14 % |
| AGOMAB THERAPEUTICS SA | 9,100 | 145.8K $ | 0.01 % |
| Ionis Pharmaceuticals Inc | 100 | 8.1K $ | 0.00 % |